Palumbo Wealth Management LLC Exagen Inc. Transaction History
Palumbo Wealth Management LLC
- $251 Million
- Q3 2024
A detailed history of Palumbo Wealth Management LLC transactions in Exagen Inc. stock. As of the latest transaction made, Palumbo Wealth Management LLC holds 76,364 shares of XGN stock, worth $298,583. This represents 0.09% of its overall portfolio holdings.
Number of Shares
76,364
Previous 66,669
14.54%
Holding current value
$298,583
Previous $121,000
94.21%
% of portfolio
0.09%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding XGN
# of Institutions
38Shares Held
6.41MCall Options Held
4.5KPut Options Held
400-
Rtw Investments, LP New York, NY1.51MShares$5.91 Million0.07% of portfolio
-
Cowen And Company, LLC891KShares$3.49 Million0.07% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY541KShares$2.11 Million0.01% of portfolio
-
Stonepine Capital Management, LLC Bend, OR534KShares$2.09 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$1.92 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $63.6M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...